Drug interactions
Metformin-pioglitazone + Nicardipine
Severity: Minor
Metformin-pioglitazone and Nicardipine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dihydropyridine calcium channel blockers such as nicardipine can modestly impair insulin secretion and glucose tolerance in some patients. This may slightly weaken glycemic control in patients taking metformin-pioglitazone. The effect is usually small and clinically manageable.
What this interaction means in plain words
Metformin-pioglitazone and Nicardipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Metformin-pioglitazone belongs to Endocrine; Nicardipine belongs to Cardiovascular.
Why it happens
Calcium channel blockade may reduce calcium-dependent pancreatic insulin release and cause mild peripheral insulin resistance, opposing the hypoglycemic effect.
What to do
Monitor blood glucose and HbA1c when nicardipine is started or stopped, and adjust antidiabetic therapy only if control changes.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Metformin-pioglitazone and Nicardipine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-pioglitazone
Other interactions of Nicardipine
Frequently asked questions
Can I take Metformin-pioglitazone with Nicardipine?
MediHelp rates the interaction as minor. Metformin-pioglitazone and Nicardipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dihydropyridine calcium channel blockers such as nicardipine can modestly impair insulin secretion and glucose tolerance in some patients. This may slightly weaken glycemic control in patients taking metformin-pioglitazone. The effect is usually small and clinically manageable.
How serious is the interaction between Metformin-pioglitazone and Nicardipine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c when nicardipine is started or stopped, and adjust antidiabetic therapy only if control changes.
What other medicines interact with Metformin-pioglitazone?
MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
